CD4 and neoplasm: To this aim, different latent and lytic cycle antigen-specific CD4+ T-cell clones, that recognize and growth-inhibit unmanipulated LCL to various degrees in vitro[19], [30], were injected together with autologous LCL or PBMC and tumor latency analyzed.